Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ocular Therapeut 24 CROSBY DRIVE BEDFORD MA 01730 USA

P: 781-357-4000 F: 781-357-4001

Description:

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular Therapeutix, Inc. is headquartered in Bedford, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 298,799
Enterprise Value, $K 159,639
Shares Outstanding, K 77,010
Annual Sales, $ 43,520 K
Annual Net Income, $ -6,550 K
Last Quarter Sales, $ 11,970 K
Last Quarter Net Income, $ -24,190 K
60-Month Beta 1.34
% of Insider Shareholders 3.60%
% of Institutional Shareholders 55.40%
Float, K 74,238
% Float 96.40%
Short Volume Ratio 0.47

Growth:

1-Year Return -29.01%
3-Year Return -11.01%
5-Year Return -25.10%
5-Year Revenue Growth 2,202.65%
5-Year Earnings Growth 45.56%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.30 on 11/07/22
Next Earnings Date 02/27/23
Earnings Per Share ttm -1.03
EPS Growth vs. Prev Qtr -7.14%
EPS Growth vs. Prev Year -30.43%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

OCUL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -87.18%
Return-on-Assets % -33.69%
Profit Margin % -15.05
Net Margin % N/A
Debt/Equity 1.15
Price/Sales 6.44
Price/Cash Flow N/A
Price/Book 6.51
Book Value/Share 0.60
Interest Coverage -0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar